​

Funding Round

Series B - DNAtriX

Series B - DNAtriX

Investment Firm

Overview

DNAtriX is a biotechnology company developing an oncolytic virus platform for treating malignant glioma.

Announced Date

Oct 14, 2014

Closed on Date

Oct 14, 2014

Funding Type

Series B

Highlights

Location

United States, North America

Social

Investor Lead

Morningside Venture Investments

Morningside Venture Investments

Morningside Venture Investments is a private_equity and venture firm.

Participant Investors

4

Investor Name
Participant InvestorMorningside Venture Investments
Participant InvestorDFJ Mercury
Participant InvestorTargeted Technology Fund
Participant InvestorTexas HALO Fund

Round Details and Background

DNAtriX raised $20000000 on 2014-10-14 in Series B

DNAtriX is a biotechnology company developing an oncolytic virus platform for treating malignant glioma.

Company Funding History

13

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Feb 24, 2014
Grant - DNAtriX
1-10.8M
Aug 27, 2013
Debt Financing - DNAtriX
1-840.0K
Nov 07, 2013
Debt Financing - DNAtriX
1-1.5M
Aug 03, 2012
Seed Round - DNAtriX
-885.6K

Recent Activity

There is no recent news or activity for this profile.